Results 11 to 20 of about 39,720 (193)
Multidrug-resistant tuberculosis
Brazilian Journal of Infectious Diseases, 2013 Despite the efforts made worldwide to reduce the number of cases of drug-susceptible tuberculosis, multidrug-resistant tuberculosis (MDR-TB) constitutes an important public health issue. Around 440,000 new cases of MDR-TB are estimated annually, although
Antônio Carlos Moreira Lemos +1 more
doaj +12 more sources
Multidrug-resistant tuberculosis [PDF]
BMC Infectious Diseases, 2008 Background With almost 9 million new cases each year, tuberculosis remains one of the most feared diseases on the planet. Led by the STOP-TB Partnership and WHO, recent efforts to combat the disease have made considerable progress in a number of ...
McNerney Ruth, Zager Ellen M
doaj +4 more sources
Multidrug-resistant tuberculosis [PDF]
The Lancet, 2019 The ideal number of drugs needed and treatment duration are crucial issues in the management of multidrug-resistant tuberculosis (MDR-TB). Thus, we read with interest the Article by the Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017,1 the results of which support our proposal,2 from 2015, to classify anti ...
Caminero, José A . +2 more
+13 more sources
Multidrug resistant tuberculosis [PDF]
BMJ, 2015 #### The bottom line Tuberculosis remains a major cause of morbidity and mortality globally, with an estimated nine million people developing the disease and 1.5 million deaths in 2013; equating to 4100 deaths a day.1 Nevertheless, considerable gains have been made in international tuberculosis control; incidence rates are decreasing (albeit slowly ...
Millard, James +2 more
openaire +2 more sources
Multidrug-Resistant Tuberculosis
Chest, 2006 Multidrug-resistant tuberculosis (MDR-TB) caused by Mycobacterium tuberculosis resistant to both isoniazid and rifampicin with or without resistance to other drugs is among the most worrisome elements of the pandemic of antibiotic resistance. Globally, about three per cent of all newly diagnosed patients have MDR-TB.
S K, Sharma, A, Mohan
openaire +2 more sources
An update on multidrug-resistant tuberculosis [PDF]
Clinical Medicine, 2019 Of the 10 million incident cases of tuberculosis (TB) globally in 2017, around 558,000 cases were rifampicin-resistant of which 82% were multidrug-resistant (MDR) TB. In England, 5,102 cases were recorded of which 55 cases (1.8%) were MDR-TB. MDR-TB cases have worse outcomes and are a serious public health issue.Polymerase chain reaction (PCR) tests ...
Park, M, Satta, G, Kon, OM
openaire +3 more sources
Brazilian Journal of Infectious Diseases, 2016 Multidrug-resistant tuberculosis (MDRTB) is a serious world health problem that limits public actions to control tuberculosis, because the most used anti-tuberculosis first-line drugs fail to stop mycobacterium spread.
Luita Nice Café Oliveira +5 more
doaj +1 more source
Multidrug-resistant tuberculosis today [PDF]
Bulletin of the World Health Organization, 2012 The World Health Organization (WHO) and its partners have long conducted efforts to improve tuberculosis (TB) case surveillance and programme monitoring and evaluation. WHO’s 2011 report on global TB control1 provided the most reliable information ever generated on the burden of disease and death caused by TB and multidrug-resistant TB (i.e.
Matteelli, A. +3 more
openaire +4 more sources
Use of the GenoType MTBDRplus for early diagnosis of multidrug-resistant tuberculosis
Zaporožskij Medicinskij Žurnal, 2017 The type of diagnostics methods and their duration, loss of time for the appointment of the optimal treatment are the major categories of factors that influence on multidrug resistant tuberculosis treatment effectiveness.
O. M. Raznatovska +4 more
doaj +1 more source
Spatial patterns of multidrug-resistant tuberculosis: correlation with sociodemographic variables and type of notification [PDF]
Revista Brasileira de Enfermagem, 2020 Objective: Correlate the cases of multidrug-resistant tuberculosis and its spatial patterns with the type of notification and sociodemographic variables.
Ingrid Bentes Lima +6 more
doaj +3 more sources